Phenotypes associated with this allele
|
|
| Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Col1a1tm1(tetO-Irf4)Sing mutation
(0 available);
any
Col1a1 mutation
(160 available)
Gt(ROSA)26Sortm1(rtTA*M2)Jae mutation
(30 available);
any
Gt(ROSA)26Sor mutation
(944 available)
Irf4tm1Mak mutation
(2 available);
any
Irf4 mutation
(27 available)
|
|
|
hematopoietic system
|
|
• doxycycline-treated mice exhibit enhanced plasma cell generation at the expense of class switch recombination
|
|
|
• doxycycline-treated mice exhibit enhanced plasma cell generation at the expense of class switch recombination
|
immune system
|
|
• doxycycline-treated mice exhibit enhanced plasma cell generation at the expense of class switch recombination
|
|
|
• doxycycline-treated mice exhibit enhanced plasma cell generation at the expense of class switch recombination
|
|
|
| Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Col1a1tm1(tetO-Irf4)Sing mutation
(0 available);
any
Col1a1 mutation
(160 available)
Gt(ROSA)26Sortm1(rtTA*M2)Jae mutation
(30 available);
any
Gt(ROSA)26Sor mutation
(944 available)
Irf4tm1Mak mutation
(2 available);
any
Irf4 mutation
(27 available)
|
|
|
hematopoietic system
|
|
• doxycycline-treated mice exhibit enhanced plasma cell generation at the expense of class switch recombination but not as severe as in mice heterozygous for Irf4tm1Mak
|
|
|
• doxycycline-treated mice exhibit enhanced plasma cell generation at the expense of class switch recombination but not as severe as in mice heterozygous for Irf4tm1Mak
|
immune system
|
|
• doxycycline-treated mice exhibit enhanced plasma cell generation at the expense of class switch recombination but not as severe as in mice heterozygous for Irf4tm1Mak
|
|
|
• doxycycline-treated mice exhibit enhanced plasma cell generation at the expense of class switch recombination but not as severe as in mice heterozygous for Irf4tm1Mak
|
Analysis Tools